Statins are thought to be protective against HCC as they decrease hepatic expression of angiogenic factors like vascular endothelial growth factor receptor (VEGFR), epidermal growth factor receptor (EGFR), and platelet-derived growth factor (PDGF) [13]. Here, EGFR is linked to hepatocellular carcinoma.